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ABSTRACT 
Hematopoiesis is a physiological process responsible for the generation of all the blood and 
immune cells of the body. The cells responsible for this process are the hematopoietic stem cells 
(HSCs), primarily located within the bone marrow. They are housed in specific 
microenvironments (niches) that provide stochastically and temporally mutable signals that 
influence stem cell fate of differentiation, quiescence, self-renewal and apoptosis. The niche 
signals may also contribute to HSC disregulation and hematopoietic pathologies, notably 
leukemia stem cell (LSC) mediated leukemogenesis. The niche consists of several components 
such as the extracellular matrix (ECM), surrounding niche cells and several soluble or ECM-
bound factors that influence the HSC fate. Critical as the function of the niche seems, 
surprisingly little is known about these regulatory processes and the mechanisms governing 
them. This thesis attempts to provide an engineering solution to understanding the complex 
biological mechanism of HSC-niche cell interaction and its influence on HSC fate. We believe 
that combinatorial biomaterials can be used to systematically expose discrete populations of 
HSCs and niche cells to defined 3D microenvironments; such tools can generate critical 
information to help decode the interrelationship between extrinsic cues, intracellular signaling 
networks, and HSC fate.  
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CHAPTER 1: INTRODUCTION 
 
Adult stem cells represent an exciting and promising class of tissue engineering based 
research for the development of clinical and therapeutic remedies for a host of diseases and 
injuries. They have the capacity to self-renew, thus maintaining their population within the body, 
while simultaneously differentiating into a defined set of mature cells (based on the adult stem 
cell) that are responsible for support and repair of the specific location of the host tissue
1
. 
Understanding the biology of stem cells will better equip us to provide medical solutions to a 
number of diseases while further advancing the field of regenerative medicine. This thesis 
attempts to provide quantitative engineering solutions for understanding the biology of 
hematopoietic stem cells (HSCs). 
 
1.1 The HSC niche 
The entire host of blood and immune cells within the body is generated from HSCs. This 
process is termed ‗Hematopoiesis‘2, and is undoubtedly one of the most critical physiological 
processes within the body. Adult HSCs are primarily located within the bone marrow (BM) in a 
complex 3-dimensional network of medullary vascular sinuses and various other cell types. The 
BM provides a specific microenvironment (niche), for the regulation and maintenance of stem 
cells. The HSC niche is known to be dynamic in nature, consisting of several factors such as the 
extracellular matrix (ECM), other cells present in the niche (niche cells) and a host of soluble 
biomolecules that assist in the regulation/disregulation of HSC biology 
3-5
. The femoral BM 
cavity, one site for the proposed niche, is one of the largest BM containing regions within the 
body. The femoral BM is divided into the proximal (hip) and distal (knee) metaphyses, separated 
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by the diaphyses, or the long bone region (Fig. 1.1). The HSC niches are supposed to exist within 
these distinct regions, defined by cell-cell and cell-ECM interactions. However, the metaphyseal 
and diaphyseal regions, as well as the potential niches within these regions, are significantly 
different. The diaphysis is primarily made up of a tube of cortical (compact) bone that defines 
the femoral shaft. The diaphyseal BM cavity contains hematopoietic cells, mesenchymal cells, 
stromal cells, fat and a vasculature system. The metaphyses are made up primarily of porous 
trabecular bone. This porous bone has a high bone surface area to BM volume ratio compared to 
the cortical bone that ensheaths the disphyseal region. The BM spaces (pores) within the 
trabecular bone structure are on order a few hundred micrometers in diameter. The metaphyseal 
regions have the highest density of arteries and veins within the BM. The surface of individual 
trabeculae is covered with osteoblasts, derived from MSCs and responsible for producing new 
bone tissue, and osteoclasts, derived from HSCs and responsible for resorbing bone
6
. The 
marrow spaces between trabeculae are filled with hematopoietic cells, BM stromal and reticular 
cells, fat and a vasculature system. HSCs may lodge in distinct regions of the metaphyses, where 
(like in the diaphyses) each region may have multiple niches associated with it.  
 
1.1.1 The endosteal and vascular niche 
Two morphologically diverse areas and their associated cellular constituents have been 
most commonly hypothesized as potential HSC niches in the BM: the endosteal (bone) niche, 
which is contact with the bone surface and specialized osteoblasts and the vascular niche, known 
to be on contact with vessels and endothelial cells 
3-5, 7
(Fig 1.2). There has been a lot of work 
underlining the functional importance of osteoblasts in regulating the HSC niche
8, 9
. BM stromal 
cells expressing CXCL-12
10
 were observed both surrounding the niches as well as in stem cell 
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vicinity. Apart from these cells, other cell types such as the vascular endothelial cells, IL-7 
expressing cells have been identified at the niche site, supporting the idea that cell-cell contact 
plays a major role in determining HSC fate 
8, 11
. However, these proposed ideas have been 
derived from indirect relationships, mainly by up-regulating or down-regulating niche cell 
population (eg. Osteoblasts), or detecting the presence of cells (such as CXCL12-expressing 
cells) near the stem cells 
12, 13
. Since HSCs are a rare population within the bone marrow (1 in 
every 250,000 cells) conclusive evidence pertaining to niche cell interactions remains elusive
5
.  
 
1.2 Influence of niche interactions on HSC fate 
The niche environment is such that it assists the regulation of a constant population of HSCs 
while developing its mature progeny. The various components of the niche: the ECM, niche cells 
and soluble regulators, are hypothesized to play a critical role in directing specific cues for the 
development of the stem cells
14
. The ECM surrounding the HSCs within the BM is of varied 
composition, stiffness and porosity. The two hypothesized niches (bone vs. vascular) contain 
significantly different ECM protein and mineral chemistry as well as microstructural 
organization
15
. The influence of matrix elasticity on HSC differentiation has been recently 
demonstrated
16
. Therefore, a similar effect can be expected from HSC-niche cell interaction. The 
niche cells surrounding the HSCs are site specific. Osteoblasts-HSC interaction is expected in the 
endosteal niche whereas the vascular niche is expected to exhibit CXCL12 expressing or 
vascular endothelial cell-HSC interaction
2, 6
. Interactions between the cells also differ based on 
whether they are direct (juxtacrine) or indirect (paracrine) mediated signaling
17
. Owing to the 
various types of cells involved, and the varying degrees of interaction to which the HSCs could 
be subjected, there are a large number of possibilities for the cumulative effect of these cues on 
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HSC fate. Coupled with the ECM interactions, soluble regulators and proteins, the system 
possesses a high degree of complexity, which cannot be decoded without a systematic approach.  
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1.3 Figures 
 
 
Figure 1.1. Anatomical features of the femoral BM microenvironment that contains HSC niches. 
The cavity is divided into the proximal (hip) and distal (knee) metaphyses.  
 
 
Figure 1.2. The endosteal and vascular niche present in the bone marrow. Each niche is 
hypothesized to perform specific functions (individually or in conjugation) for HSC 
maintenance
2
.  
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CHAPTER 2: ADULT HSCs AND THE ROLE OF BIOMATERIALS 
 
2.1 Fate of the adult HSC 
All functional cells express specific surface markers that characterize them. This makes it 
possible to differentiate between the tiny populations of adult HSCs from the large populations 
of BM cells (0.5% HSCs from the BM). HSCs are mainly characterized by the absence of the 
lineage surface marker (Lin
-
) and the presence of two stem-cell antigens c-Kit and Sca-1 (c-Kit
+
, 
Sca-1
+
) while also including additional markers of the SLAM family
5
 CD150
+
CD244
-
CD48
-
. 
Hematopoietic stem progenitor cells (HSPCs) however, are identified by the Lin
-
c-Kit
+
Sca-1
+
 
(LSK) surface markers
18
. The HSCs are therefore a rarer population compared to HSPCs within 
the bone marrow and hence harder to isolate. We will initially focus of HSPCs, eventually 
working our way up to HSCs.  
There are different categories of HSCs, namely the long-term HSC (LT-HSC) and the short-
term HSCs (ST-HSCs). They can be further identified with additional markers
2
 (Figure 2.1). The 
LT-HSCs have the potential for self-renewal and are typically the dormant subset of the stem cell 
population. As the primary function of HSCs is to maintain homeostasis, it is essential to have a 
population that primarily serves to replenish the cells that differentiated into the hematopoietic 
cells, a task handled by LT-HSCs. ST-HSCs have a limited self-renewal capacity and mainly 
differentiate further down the hematopoietic system to create more mature cell types
19
. The 
differentiation pathway of HSCs is given in Figure 2.2
20
. Each cell type is identified by specific 
markers, an attribute crucial in isolating them from large populations.  
Although hematopoietic cells are ultimately replaced by HSCs, they are more directly 
generated from committed progenitors. Homeostasis affects the number of these progenitors as 
well as the ratio between quiescent and self-renewing HSCs. The initial differentiation step that 
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follows stem cells is the commitment between common lymphoid progenitors (CLP) and 
common myeloid progenitors (CMP); the progenitors for the myeloid and lymphoid type cells
19, 
21
. It is necessary to investigate the impact of these committed progenitors on the hematopoietic 
system, and ultimately the HSCs in order to completely understand the key regulatory events of 
the hematopoietic differentiation pathway.  
 
2.2 Cell- mediated and cytokine-mediated interactions 
There has been well documented evidence of the presence of other cell types influencing the 
target cell functionality. The expression of cell adhesion molecules by cells such as 
mesenchymal stem cells (MSCs) or embryonic stem cells (ESCs) has already been determined
22, 
23
. As demonstrated by Segers
22, 24
 et al. VCAM1, which interacts with integrin α4, was the 
dominant adhesion molecule in the cytokine-induced adhesion of MSCs to cardiac microvascular 
endothelium (CMVE). However, VCAM1 was not the only adhesion molecule and their work 
suggested that the MSC adhesion to CMVEs was controlled by variations in VCAM1 expression 
levels, along with other molecules. The impact of cell adhesion molecules on stem cell fate is not 
fully understood, partly because the effect of these molecules, individually and as a system have 
not been studied systematically. This holds true especially for the hematopoietic system as much 
works needs to be done in order to understand the cell-based signaling within the HSC niche. 
Mobilization and stromal cell interactions of hematopoietic precursors are thought to be 
controlled by cytokines, particularly, chemokines such as CXCL12 and SDF-1.
25
 Notch-based 
signaling is thought to be involved in many cell-fate decisions
11, 26-28
. Several notch receptors and 
ligands (Notch-1/2 receptors and Jagged1 ligand) are expressed in the bone marrow cells, 
introducing the possibility of their potential effects on HSC fate. Membrane bounds stem cell 
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factor (SCF) binds and activates KIT ligand, highly expressed in HSCs. SCF is also known to 
activate VLA-4 and VLA-5, responsible for adhesion to stromal cells. Up-regulation of N-
cadherin, expressed by osteoblasts, has been known to affect the HSC population. Research on 
other molecules and the corresponding cells expressing them, such as CXCL12 reticular cells 
and IL-7 expressing cells, present in the vascular niche, has not yet proved their impact, if any, 
on HSC biology, much less quantified it kinetically (Figure 2.3)
2
.  
2.3 Role of Biomaterials  
It has become increasingly clear that spatial and temporal heterogeneities within the HSC 
niche play a role in modulating HSC behavior. However, the mechanisms underlying these 
regulations are not well known. Recent efforts have been directed towards isolating the various 
signals exchanged between HSCs and their niche environment. However, owing to the 
complexity of the system, a systematic investigation of the biophysical cues regulating HSC fate 
is necessary. Although advances in genomics, proteomics and systems biology have been 
enabled by combinatorial methods that permit high throughput, multiscale analyses; no 
equivalent 3D combinatorial biomaterials exist to facilitate the decoding of interrelationship 
between extrinsic signals and cell fate. A synthetic HSC niche will enable us to control the local 
microenvironment of the HSC while isolating the various cues known to govern HSC fate. The 
biomaterial system under consideration needs to have the important attributes of versatility and a 
high throughput capability; enabling us to vary multiple parameters collectively. This thesis 
describes the development of novel biomaterials that can be used as a model system to engineer a 
synthetic HSC niche; providing the necessary control over the niche environment while also 
enabling a quantitative and systematic approach towards decoding the relationship between 
extrinsic cues and internal signaling cascades that govern HSC fate.  
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2.4 Figures 
 
Figure 2.1. Surface markers help in identifying various subsets of the hematopoietic stem cell 
populations. As shown above, a difference in the surface markers being expressed enables us to 
differentiate between various cell types. Multipotent Progenitor (MPP) cells are the next 
differentiated cell type after ST-HSCs
2
.  
 
 
 
Figure 2.2. The HSC differentiation pathway. The original adult stem cell undergoes multiple 
changes in functionality before finally developing into mature cells that partake in hematopoiesis 
(modified from Passegue et al. 
20
) 
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Figure 2.3. Schematic diagram of the endosteal niche–stem-cell synapse showing putative 
ligand–receptor interactions and adhesion molecules, as described by Wilson et al2. The various 
ligand/receptors and their functions are given in the table below.  
 
2.5 Tables 
 
Molecule Function Molecule Function 
BMI1 Polycomb repressor CXCR4 CXC-chemokine receptor 
4 
BMP Bone morphogenic protein FAK Focal adhesion kinase 
BMPR1A BMP receptor 1A HOXB4 Homeobox B4 
CXCL12 CXC chemokine ligand 12 ICAM1 Intercellular adhesion 
mol 1 
SNO Spindle-shaped N-cadherin-expressing 
osteoblasts 
OPN osteopontin 
VCAM1 Vascular cell-adhesion molecule 1 VLA4 Very late antigen 4 
LFA1 Lymphocyte function associated antigen - 1 PTH Parathyroid hormone 
PLC Phospho lipase C PKC Protein kinase C 
 
Table 2.1. The various ligand/receptors and their corresponding functions are given in the table
2
.  
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CHAPTER 3: APPROACH 
 
The hematopoiesis differentiation pathway is extremely elaborate and complicated. 
Therefore, we consider a defined aspect of early HSPC differentiation, namely the generation of 
myeloid and lymphoid progenitors; cells that have lost their regenerative ability but possess 
characteristics for a more directed differentiation (Figure 3.1)
19
. We have created a biomaterial 
tool that enables a high throughput approach to address difficulties regarding assessing the role 
cell-cell interactions play in the HSPC niche. There potentially exists, a large number of 
variations in the niche regulatory system that can affect HSPC fate: 1) the multitude of potential 
cell types within the niche; 2) multiple mechanisms (juxtracrine, paracrine) of HSC-niche cell 
interaction; 3) presence/absence of additional soluble biomolecules in the BM. Hence, it is 
essential to decode the effects of all possible parameters on HSPC fate to develop our 
understanding of the stem cell niche. 
Microfluidic technology enables the generation of continuous gradients of either cells or 
biomolecules or even ECM. Such gradients play an important role in many biological processes 
such as embryonic development, tissue regeneration, or tumor metastasis
29
. During development, 
a multitude of overlapping gradients of signaling molecules, termed morphogens
29-31
, govern the 
transformation of an initially homogeneous cell mass into an organized arrangement of 
differentiated cells that, when fully developed, make up a tissue or an organ. In vivo, the 
establishment of morphogen gradients is tightly regulated by their binding to ECM components. 
ECM binding not only limits the diffusion of morphogens, but can also increase signaling 
activity by clustering morphogens such as fibroblast growth factors (FGFs) or bone morphogenic 
proteins (BMPs) at the cell surface
29, 32
. Creating controllable gradient profiles will greatly 
12 
 
enhance our ability to mimic aspects of the in vivo HSPC niche, and can also serve as a platform 
for the development of synthetic in vitro niches for HSPC development.  
The concept of multi-gradients can be used to examine a large number of variables with a 
combinatorial approach. This enables the quantitative analysis of a large number of cells, 
including the rare HSPCs in a systematic fashion. We create multiple opposing gradients of cells 
and/or hydrogel biomaterials in a novel multi-gradient microfluidic experimental chamber to 
encapsulate a small number of HSPCs and niche cells (Figure 3.2). Discrete points along the 
gradients within this chamber contain defined ratios of HSC:niche cells or ECM proteins, 
thereby providing a homologous series of microenvironments for the HSPC culture. The gradient 
hydrogels are designed such that fluorescent imaging of the cells embedded in the ECM is 
possible. Fluorescent imaging approaches enables real-time, in situ analysis of HSC behavior. 
We intend to characterize the cells via imaging as well as through direct analysis. Quantitative 
analysis is possible by isolating distinct regions from the hydrogel for FACS
33
, gene 
expression
34
, and functional (colony forming, repopulation) assays
35
. We hypothesize that co-
modulating the local niche cell and hydrogel densities within the chip and applying biomolecule 
agonists/antagonist of known HSC signaling cascades will enable us to directly quantify the role 
direct (cadherin-mediated) vs. indirect (paracrine signaling) interactions between niche cells and 
HSCs play in early HSC fate decisions.   
The critical aspect of this project was the consistent generation of gradient hydrogels. The 
system had to be capable of creating gradients for cells of any size, while also being flexible with 
the hydrogel in which the cells are embedded. This thesis describes the generation of such 
gradient hydrogels. For this purpose, collagen I, the most abundant type of collagen found in the 
human body was used as the ECM
36
.  
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3.1 Figures 
 
Figure 3.1 Initial differentiation pathway of the HSC. The first prominent change in 
functionality occurs as the stem cell differentiates into a multipotent progenitor (MPP), capable 
of a more directed differentiation but limited in self-renewal capacity. Common myeloid 
progenitor (CMP) and common lymphoid progenitor (CLP) are the precursors for their 
respective blood types in the hematopoietic pathway. This differentiation step forms the focus for 
the development of the biomaterial systems.  
 
 
 
 
Figure 3.2. A schematic of the gradient mold (left). The arrows indicate concentration profiles of 
two separate components lodged within the cavity of the mold. The component profile could 
either be for cells or microbeads or ECM density. The 5 sections can be isolated for analysis post 
culture. The gradient enables isolation of defined ratios of HSPCs:niche cells which can be 
analyzed further.  
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CHAPTER 4: EXPERIMENTS 
 
4.1 Microfluidic gradient-generator 
Microfluidic devices have been an increasingly popular method for the study of systems on a 
micro scale. These devices provide a level flexibility to the system that is not possible via 
conventional methods. Our objective is to study cell-cell interactions by creating gradient 
systems with a high degree of versatility. The use of rare cells such as HSPCs makes it necessary 
to limit the size of the system while also being capable of performing quantitative studies. 
Mircofluidic devices prove to be a very useful option for this purpose.  
The use of microfluidic diffusive mixers for generating gradients is not uncommon. Diffusive 
gradients consisting of a network of microchannels have been used in the past
29, 37
. The devices 
work by serially mixing and diluting two or more input streams via a pattern of curved channels 
that serve as paths for diffusive mixing to take place. The extent of mixing and the final 
concentration is a function of the length of the channels. This model, however, works only for 
the diffusive mixing of solutions. Any particles or heterogeneities, if present, will not be mixed 
with the oncoming streams as, in the absence of chaotic mixing, diffusive mixing is the only 
driving force, which for large particulates is inadequate for obtaining the desired mixing. The 
diffusion will be too slow for the time periods under consideration. In order to induce the mixing 
of heterogeneities present within the solutions, additional features, in the form of herringbone 
structures need to be patterned within the channels
38
. These structures induce chaotic advection 
in a direction perpendicular to the fluid flow, resulting in a complete mixing of the incoming 
fluid streams. These gradient devices are made via photolithography and consist of a patterned 
polydimethylsiloxane (PDMS) surface bonded to a glass slide (Appendix A.1 and A.2).  
15 
 
The final structure of the device used for creating these gradients is shown in Figure 4.1. The 
channel dimensions are 100 µm deep and 200 µm wide. The herringbone structure is 50 µm high 
and 150 µm wide. The purpose of this device is to create solutions at different concentrations, 
separated in a gradient form, from an initial solution of cells and ECM. Since the objective was 
to study cell-cell interaction of HSCs with other niche cells, we created two inputs to the device; 
serving as entry points for a solution of cells and matrix of two different types. These solutions 
were then serially mixed along the channel lengths which included the herringbone structures for 
advective mixing. The final output of the device consisted of the 2 input streams being split into 
10 output streams; each with a unique concentration ratio of the input solutions. This consisted of 
the first step of our gradient generator. These 10 individual streams needed to be coupled 
together, in order to create a continuous gradient profile of the two input components. For this 
purpose, we created a mold that served as a reservoir for the cells.  
 
4.2 The Teflon mold  
Multiple designs were tested in order to create the perfect mold, which could serve not only 
as a reservoir for the cell and ECM, but also be capable of post fabrication analysis. Some of the 
requirements for this mold were: 
1) Ability to image the cells encapsulated in the ECM within the mold cavity  
2) Ease of access to the cells, post fabrication, for supplying nutrients and media  
3) The ability to isolate distinct regions within the mold for analysis post culture 
4) Non-toxic components used to make the mold 
16 
 
Multiple iterations of molds were tested and the final design is shown in Figure 4.2. The 
mold is a made of Teflon with inner dimension of 1.5 x 8 x 1.5 mm (total volume of ≈ 180µL). 
This mold cavity serves as the reservoir for the cells to be cultured in after the gradient 
generation step. The microfluidic device is connected to the mold through the use of metallic 
tubes (stainless steel, gauge 25). 10 tubes on each side of the mold serve as inlets and outlets. In 
order to prevent the contents in the mold from spilling while generating the gradient, the top and 
bottom of the mold is encased with cover slips. This also enables imaging (fluorescent and 
optical) at any time post fabrication. The cover slip at the bottom of the mold is glued using 
super glue. This serves as a firm base for the cell and matrix solution. For the ease of access to 
the cells, the cover slip on top is attached by means of high vacuum grease (nontoxic, 
nonreactive), which can be slid off the Teflon mold whenever needed. This unique mold design 
allows us to combine the various stream concentrations in a single reservoir while also enabling 
cell analysis post fabrication and culture.  
In order to isolate the regions within the mold for analysis, we have created a comb structure 
made of aluminum plates (Figure 4.3). This comb, with dimensions that allow it to be placed 
within the mold cavity (15 mm x 8 mm), splits the device into five equal parts. Solutions from 
each section are pipetted carefully into separate containers. Typically a volume between 25 – 30 
µL is recovered from each section. These samples can be subsequently analyzed for flow 
cytometry, surface antigen expression, gene expression etc.  
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4.3 Gradient components: cells, beads and collagen 
The concept of the gradient maker was initially tested on fluorescent microbeads: 
FluoSpheres Yellow/Green (Excitation: 505/15 nm, Emission: 515/15 nm) and FluoSpheres Red 
(Excitation: 575/25, Emission: 610/25), obtained from Invitrogen. The beads (1 µm diameter), 
mixed with varying collagen densities, were used to create these defined gradients. They served 
as a basis for subsequent cell based experiments for determining the flow rates and flow 
durations. After successfully proving the ability of the gradient device through the use of beads, 
cells were used to create these defined gradients under the same conditions.  
MC3T3-E1 pre-osteoblasts, a putative niche cell, were used for generating the gradients. 
They are readily available as a well established cell line from ATCC. Cells up to a passage 
number of 30 were used (Appendix A.3). For the purposes of identification post gradient 
formation, different populations of cells were tagged with two specific dyes: CMFDA 
(Excitation: 490/15 nm, Emission: 520/30 nm) and CMTPX (Excitation: 580/30 nm, Emission: 
610/30 nm), obtained from Invitrogen, as described in the protocol in Appendix A.4.  
Hematopoietic stem/progenitor cells were isolated as Lin
-
c-Kit
+
Sca-1
+
 cells from the femur 
and tibia of 4 – 8 week old mice, as described in the protocol in Appendix A.5). The cells were 
isolated from the general BM population using fluorescence activated cell sorting (FACS). Due 
to their rarity, a limited number of gradients were characterized via these HSPCs.  
Collagen solutions of varying densities were made for each experiment as described in 
Appendix A.7. This, while allowing for multiple culture conditions, also demonstrated the 
versatility of the gradient maker in terms of the solutions used. Collagen can be gelled via 
incubation for a few hours
36
. However, this does not restrict us to the use of collagen as an ECM. 
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Any solution that can flow through these channels can be used as an ECM, which can be gelled 
by heat treatment or even photopolymerization, a technique that has been successfully used 
before for such gels
39, 40
.  
 
4.4 Device operation 
We intend to create gradient hydrogels of stem cells and niche cells encapsulated within an 
ECM, namely Collagen type I. Thus, by nature of this design, the cultures of HSPCs and niche 
cells will be 3 dimensional, an attempt to mimic in vivo niches as close as possible. A detailed 
protocol for the gradient generation is given (Appendix A.6). Briefly, we load a solution of 
collagen and the cells in a specific concentration into a 1 ml syringe. The syringe is then loaded 
onto a syringe pump (Harvard Apparatus, Harvard 33 twin syringe pumps), capable of pumping 
the solution at a specific flow rate (flow rates for various conditions provided in Table 4.1). The 
syringes are connected to the microfluidic device via plastic tubes while the teflon mold is 
attached to the device via the 10 metal tubes. In order to prevent air bubbles trapped within the 
device or the tubes to be a hindrance to the gradient formation process, we first pull vacuum 
within the system while keeping it immersed in sterile water. This prevents any further air to be 
trapped within. Depending on the density of collagen used (typically ranging between 1 – 2.5 
mg/mL), the flow rate of the syringe pump, along with the flow duration is adjusted. After 
running the pump for a specific time, the teflon mold is detached from the entire setup and 
placed in the incubator for cell culture. The flow rates and flow times for the various densities of 
collagen are given in Table 4.1. The collagen gel thus formed was gelled via incubation at 37 °C 
for 1 – 2 hours.  
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4.5 Gradient characterization 
The quality of the gradients was characterized via fluorescence imaging. In order to best 
identify the density of population of the particulates (cells or beads) within the mold, the 
particulates were fluorescently tagged and the mold in its entirety was imaged via a scanner 
(Typhoon 9400 Image scanner, GE electronics). The fluorescence intensity within sections of the 
mold was an indicator of the population density, thus characterizing the quality of the gradient 
generated. The intensities across the mold were compared to the starting solution fluorescence, 
thus providing us with a quantitative way of assessing the gradients.  
The ability to isolate distinct regions and observing them using FACS is critical for future 
analysis of the cultured HSPCs. The populations within the gradients were analyzed using a BD 
Flow Cytometer, which identified distinct populations of the fluorescent microbeads as a 
function of location within the mold, as described in Appendix A.9 
Preliminary studies on osteoblast cell viability (Appendix A.10) after culture inside the mold 
over 6 hours were performed. This was done to demonstrate the capability of the mold as a 
viable culture vessel.  
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4.6 Figures 
 
Figure 4.1. A schematic of the microfluidic device used for creating the gradients. The curved 
channels serve as diffusion paths for the solution. The herringbone structure (inset) induces 
chaotic advection in the flow, causing particulates in the solutions to mix. The channels are 
encased between a glass slide and patterned PDMS.  
 
 
 
 
Figure 4.2. A schematic of the teflon mold. Metal tubes are attached to the teflon mold at regular 
intervals. Coverslips at the top and bottom enable imaging of the cells within the cavity. Tubes 
from either end are inserted into the PDMS device, allowing the solutions to enter mold cavity.  
 
 
Mold cavity 
Coverslip (top) 
Coverslip 
(bottom) 
Objective 
Metal 
tubes 
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Figure 4.3 A metal plate comb, designed to isolate sections within the mold. The dimensions of 
the comb match that of the mold cavity such that it can be placed directly inside it. By inserting a 
pipette from the side, the solution is isolated from each section to be taken for further analysis.  
 
4.7 Tables 
Collagen solution density 
(mg/mL) 
Pump flow rate 
(µL/min) 
Flow duration 
(secs) 
1 150 45 
1.5 180 40 
2 220 35 
2.5 270 30 
 
Table 4.1. Flow specifications for various densities of collagen. Denser collagen solutions are 
more viscous, requiring a higher flow rate and hence lower flow duration.  
 
 
 
10 mm 
8 mm 
15 mm 
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CHAPTER 5: RESULTS 
 
5.1 Bead gradient characterization 
We successfully created collagen hydrogels with a gradient bead population under different 
collagen conditions. The gradients generated were characterized based on their fluorescence as 
described in the Appendix A.8. As a proof of concept, gradients were first generated using 
microbeads (Yellow/Green and Red Fluo Spheres, 1 µm diameter, Invitrogen). All experiments 
were done at 4 different collagen densities: 1, 1.5, 2, 2.5 mg/mL. This enabled us to build a 
library of collagen gel systems with varying gel density and reflected a range of gel mechanics 
and permeabilities for which the system was tested. This enables us to model subsequent 
experiments using collagen (or any other material) based on these results.  The resultant gradient 
was scanned using the Typhoon Image scanner and the fluorescence levels obtained from those 
images were used for a quantitative measurement of gradients. A representative image along 
with an opposing-gradient profile (as a function of position) for each collagen density has been 
shown in Figures 5.1 through 5.4. 
As can be seen clearly from the graphs, we have successfully established an opposing 
concentration profile of the beads within the mold. The gradients thus generated are also 3-
dimensional in nature, a crucial aspect for subsequent in vitro cell culture studies. The graphs 
represent the average fluorescence intensity of the beads within the 5 regions, an indication of 
the average population density across each region. Thus, it is possible to isolate these regions 
within the mold, with each region a representative microenvironment comprised of unique 
conditions established by opposing gradients. The two opposing graphs are nearly symmetric, 
i.e., each red point on the graph has a corresponding green point in the opposing region of the 
mold (1 and 5, 2 and 4 are opposing regions). A symmetric system indicates reliability in terms 
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of the gradients produced. In order to best assess the changes along the mold, we took a ratio of 
the bead concentrations at their respective positions. The result, as shown in Figure 5.9 indicates 
how many of the yellow/green fluorescent beads are present in the system compared to the red 
fluorescent ones. Based on the graphs, the ratio of the concentrations at one end of the mold 
begins at around 4; dropping almost linearly along the length of the mold. We expect this very 
result because based on the microfluidic design; the two bead concentrations are highest at the 
opposing ends. Any region in between contains a mixture of the two beads. Thus, they should 
exhibit a decreasing concentration ratio across the mold. All collagen densities exhibit this trend 
of a high ratio at the beginning which gradually decreases as we serially sample the various 
regions of the mold. It must be noted that as we go higher in concentration, the peak ratio for 
each section reduces. This could be due to the fact that collagen viscosity increases with 
increasing concentration. The herringbone structure facilitates mixing via chaotic advection; a 
process that reduces in efficiency with increasing solution viscosity. Lower levels of mixing 
could explain a lower bead concentration ratio.  
 
5.2 Cell gradient characterization 
The device was also successful in generating collagen gradients consisting of cells. After 
demonstrating the gradient generation ability with beads, we tested its performance with the 
MC3T3-E1 pre-osteoblasts. These cells are considerably larger than the beads (15 – 20 µm in 
diameter). Experiments were performed for the different collagen concentrations similar to the 
fluorescent beads. The starting cell concentration varied between 200,000 – 400,000 cells per 
mL. The results are shown in Figures 5.5 through 5.8. As with the beads, the performance of the 
gradient device is tested by generating the opposing graphs of the average fluorescence intensity 
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of the cells. Again, opposing profiles of cell concentrations are observed with the mold. These 
profiles are, to a certain extent, symmetric. However, in some cases the concentration profile 
seems to be skewed indicating that within the two input solutions, one solution underwent more 
mixing within the microchannels than the other. To further assess the quality of the gradients a 
concentration ratio (based on fluorescence intensity) for the two cell types was generated, as 
shown in Figure 5.10. A trend similar to the beads is observed, i.e. a low ratio for the lowest 
density collagen (1 mg/mL), which rises for 1.5 mg/mL and then continues to decrease with 
increasing solution density. Also, the ratio of the two cell concentrations decreases along the 
length of the mold, an observation similar to that for the beads. As mentioned previously, higher 
collagen density is a possible explanation for this phenomenon. A larger cell size could also 
affect chaotic advection, making it harder for the two streams to mix properly due to a greater 
interference from the solution heterogeneities. This could also explain the skewed opposing 
gradient graphs. Although this is an unavoidable occurrence in the presence of cells, 
modifications in micro channel dimensions could possibly alleviate these problems.  
 Although the gradient performance was tested mainly on osteoblasts, preliminary 
experiments were also conducted on gradients obtained by mixing osteoblasts with primary 
HSPCs. Experiments were performed using only the 1mg/mL collagen solution density. The 
objective was to determine whether opposing gradients could be obtained with cells of different 
sizes as osteoblasts are 15 µm in diameter whereas HSCs are about 5 µm in diameter. Figures 
5.11 and 5.12 show the opposing gradients obtained using these cells. Similar to the OB-OB 
gradient ratio data for 1 mg/mL, the ratio of OB:HSC ranged between 2 and 0.5. Thus, even with 
different cell sizes, a successful gradient can be obtained; a result that further advocates the use 
of this system for creating multicellular gradients.  
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5.3 Flow analysis for bead gradients 
Flow cytometric analysis of the sections within the gradients further confirms the presence of 
distinct population ratios within each region. This was observed at all collagen densities tested 
(1- 2 mg/mL). In order to obtain a quantitative analysis of the gradients, we performed a flow 
cytometric analysis on the gradient solutions. For this purpose, we isolated the five sections 
using the metal comb and ran the solutions through the FACS machine (Appendix A.9). This 
method provided a numeric count of the numbers of fluorescent beads in each section.  
The FACS plots and the related histograms for three distinct regions within the mold are 
provided in Figures 5.13 through 5.15. Regions 1 and 5 are the extremities of the mold where 
one type of population is expected to be dominant whereas region 3, which is the centre of the 
mold, should have near equal amounts of both bead populations, as expected from a linear 
gradient profile. From figures 5.13 through 5.15, we see that the expected results are obtained. 
The graph profiles also stay constant over all collagen solution densities, an indication of the 
consistency of the system. The FACS density plots represent the two populations of beads. The 
FITC dye identifies the yellow/green beads while the Alex Flour 647 dye identifies the crimson 
spheres used for this experiment. Bead populations that are detected by the machine are 
identified as being positive for that particular dye and appear at the higher end of the x-axis or y-
axis, indicating a high fluorescence count detected by the machine.  
As a representative plot, the data for 1.5 mg/mL collagen can be considered (Figure 5.14). 
Region 1 and region 5 possess high populations of one bead type and a low population of the 
other. Thus, the FACS density plot shows populations in the 1
st
 and 3
rd
 quadrant for regions 5 
and 1 respectively. However, as can be seen from the graphs, there are bead populations in both 
quadrants. This aberration can be explained by the fact that for the purposes of numeric counting, 
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a separate population of beads was mixed with the sample and these beads had a signal similar to 
the FITC (yellow/green) beads. In order to circumvent this problem, we analyze the population 
histograms of the two beads. This data provides a clear population representation of the beads in 
the sample analyzed. As expected, we observe a sharp peak for either of the bead populations in 
regions 1 and 5. Smaller peaks are also observed, which represent part of the populations seen in 
the FACS density plots. However, their numbers are negligible. While regions 1 and 5 exhibit 
these alternating peaks, region 3 has two sharp identical peaks, indicating an equal number of 
bead populations for both the dyes. These results are consistent over all the measured collagen 
solution densities (1 – 2 mg/mL). Although results for the highest collagen density (2.5 mg/mL) 
have not been obtained, similar results are expected for it.  
This supports the conclusion that the central region of the mold contains an equal population 
of both the beads while the extremities of the mold have a prevalent population of only one kind. 
This FACS data further supports results of the population distribution obtained from the slide 
scanner images of the fluorescence intensity of the mold.  
 
5.4 Improving gradient quality 
As mentioned in previous sections, a few irregularities can be observed in the data. For 
example, the opposing gradient graphs for 1.5 mg/mL collagen solution aren‘t perfectly 
symmetrical but rather skewed towards the green side. Similarly, for the bead concentration ratio 
graph (Figure 5.9), the ratio is lower for the 1 mg/ml collagen solution, which is contrary to the 
trend observed for the rest of the collagen densities. Although aberrations, these irregularities are 
directly connected to the process of creating the gradients. It must be noted that the gradient 
generating system is composed of 2 essential components: the microfluidic device and the mold. 
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On a micro scale, the slightest of particles can obstruct fluid flow, which is critical for making 
the perfect gradient. Through observation, it has been noted that air bubbles trapped inside either 
the channels or the metal tubes pose the biggest problem for this system. An air bubble creates a 
change in the surface tension, thus disrupting the pressure gradient formed either within the 
channel or at the tube interface. This could potentially redirect fluid flow to other channels, 
leading to a bad gradient formation. We combat this issue by pulling vacuum on the system, thus 
driving out all the air from inside and replacing it with water. This results in an equalization of 
the surface tension as the entire system is replaced by water, a homogeneous fluid. However, this 
method remains to be improved upon as seen from the data.  
We propose to do so by recognizing the fact that the gradient setup can be simplified even 
further. It is impossible to avoid contact with air at any/all steps while generating the gradients. 
However, reducing the number of interfaces reduces the possible number of spots for air to be 
trapped in, while also making it easier to eliminate it from the system. Hence we propose to 
combine the device and mold into a single microfluidic chip. This device, as shown in Figure 
5.16, will form the basis for our subsequent experiments. It is our intention that the new device 
provide us with the ability to control the mold volume, which can be modified during the 
fabrication of the device master. This lets us manipulate the total number of cells cultured in the 
mold, thus giving us control over the size of our population study.  
 
5.5 Cell viability within the gradient collagen mold  
The eventual aim of generating these gradients is to provide a controllable local 
microenvironment for the co-culture of HSCs with other niche cells. Although functionality of 
the cells is a crucial aspect of this study, cell viabbility is a more basic and fundamental 
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necessity. Having healthy viable cells is absolutely essential in order to proceed with the co-
culture studies. Viability of the cells embedded in collagen was determined using a Live/Dead 
assay (Appendix A.10). Current experiments have only been limited to viability measurements 
for the 1 mg/mL collagen solution. Nevertheless, the results are encouraging. The objective was 
to determine whether the gradient making process had any detrimental effects on cell viability. 
Therefore, cell viability was monitored at two time points: right after gradient formation and 
after 6 hours. It can be safely presumed that any negative effects of gradient process such as the 
chaotic advection caused by the herringbone structures or the flow through tubes and the micro 
channels will reflect on cell viability within those initial few hours. As can be seen from Figure 
5.17, the osteoblasts exhibit a high degree of viability up to 6 hours. This is an encouraging result 
that further supports the feasibility of using the microfluidic gradient generator. However, it 
certainly warrants further studies at other collagen densities and for greater culture periods.  
 
5.6 Confocal imaging of cells within the mold 
As mentioned earlier, the mold had to be capable of fluorescence imaging so as to track the 
cells while in culture. We were able to take confocal images of the HSCs within the mold by 
tracking the surface markers c-kit and Sca-1 expressed by the cells (Figure 5.18). The images 
were taken using Multiphoton Confocal microscope Zeiss LSM 710 at the Institute of Genomics 
Biology (IGB) at UIUC. The microscope is capable of performing spectral unmixing of the two 
dyes used to identify the surface markers, while also possessing the ability to detect further 
unique fluorescence signals. This powerful tool will enable us to simultaneously track more than 
one surface markers attached to the cells, an ability crucial in tracking any functional changes 
exhibited by the HSCs in culture. Confocal imaging of the surface markers followed by 
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experiments associated with gene expression of the cells in culture provides us with the tools 
necessary to understand how the different culture conditions affect HSC functionality. This 
functionality can be further tested using standard functional assays such as Methocult, CFUs 
etc.
16
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5.7 Figures 
 
 
Figure 5.1.  A linear opposing gradient graph for fluorescent microbeads at a collagen solution 
density of 1 mg/mL is shown on the left. The figure on the left is a representative fluorescent 
image (for red and yellow/green spheres as imaged by the Typhoon scanner). The error bars on 
all the graphs represent the standard error of mean (SEM).  
 
 
Figure 5.2.  A linear opposing gradient graph for fluorescent microbeads at a collagen solution 
density of 1.5 mg/mL is shown on the left. The figure on the left is a representative fluorescent 
image (for red and yellow/green spheres as imaged by the Typhoon scanner)   
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Figure 5.3.  A linear opposing gradient graph for fluorescent microbeads at a collagen solution 
density of 2 mg/mL is shown on the left. The figure on the left is a representative fluorescent 
image (for red and yellow/green spheres as imaged by the Typhoon scanner)   
 
 
 
Figure 5.4.  A linear opposing gradient graph for fluorescent microbeads at a collagen solution 
density of 2.5 mg/mL is shown on the left. The figure on the left is a representative fluorescent 
image (for red and yellow/green spheres as imaged by the Typhoon scanner)   
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Figure 5.5.  A linear opposing gradient graph for osteoblasts (tagged with the CMFDA and 
CMTPX dyes) at a collagen solution density of 1 mg/mL is shown on the left. The figure on the 
left is a representative fluorescent image (for red and yellow/green spheres as imaged by the 
Typhoon scanner)   
 
 
 
Figure 5.6.  A linear opposing gradient graph for osteoblasts (tagged with the CMFDA and 
CMTPX dyes) at a collagen solution density of 1.5 mg/mL is shown on the left. The figure on 
the left is a representative fluorescent image (for red and yellow/green spheres as imaged by the 
Typhoon scanner)   
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Figure 5.7.  A linear opposing gradient graph for osteoblasts (tagged with the CMFDA and 
CMTPX dyes) at a collagen solution density of 2 mg/mL is shown on the left. The figure on the 
left is a representative fluorescent image (for red and yellow/green spheres as imaged by the 
Typhoon scanner)   
 
 
 
Figure 5.8.  A linear opposing gradient graph for osteoblasts (tagged with the CMFDA and 
CMTPX dyes) at a collagen solution density of 2.5 mg/mL is shown on the left. The figure on 
the left is a representative fluorescent image (for red and yellow/green spheres as imaged by the 
Typhoon scanner)   
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Figure 5.9.  A density ratio graph for the fluorescent beads at distinct regions of the mold.   
Since the fluorescent intensity corresponds directly to the density of beads in the region, a ratio 
of the fluorescence levels indicates the relative populations of the two bead types in various 
regions. We expect a high ratio at one end which gradually decreases as we reach the opposite 
end of the mold, while expecting a ratio of around 1 at the centre (region 3) 
 
 
Figure 5.10.  A density ratio graph for the fluorescently tagged osteoblasts at distinct regions of 
the mold.   Since the fluorescent intensity corresponds directly to the density of cells in the 
region, a ratio of the fluorescence levels indicates the relative populations of the two cell types in 
various regions. We expect a high ratio at one end which gradually decreases as we reach the 
opposite end of the mold, while expecting a ratio of around 1 at the centre (region 3) 
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Figure 5.11. Gradients generated using osteoblasts and HSCs at a collegn density of 1 mg/mL. 
The image on the left is a representative fluorescence image of the gradient whereas the graph on 
the right indicating the linear opposing nature of the gradient.  
 
 
 
Figure 5.12.  A density ratio graph for the fluorescently tagged osteoblasts and HSCs at distinct 
regions of the mold. Similar to the bead and osteoblasts gradients, the ratio is high at one end and 
gradually decreases across the mold.  
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1 mg/mL collagen 
 
Figure 5.13. FACS density plots (left column) and the corresponding hiostograms (left column) 
for 3 regions within the mold for gradients generated for Fluorescent beads at 1 mg/mL collagen 
density. Region 1 and region 5 represent the extremities of the mold while region 3 represents 
the centre. As expected, prevalent peaks of the two dyes are observed at the extremities and a 
roughly equal population of beads is observed at the centre. Alexa 647 and FITC are the two 
dyes detected by the system, representing the two bead populations 
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1.5 mg/mL collagen 
 
Figure 5.14. FACS density plots (left column) and the corresponding hiostograms (left column) 
for 3 regions within the mold for gradients generated for Fluorescent beads at 1.5 mg/mL 
collagen density. Region 1 and region 5 represent the extremities of the mold while region 3 
represents the centre. As expected, prevalent peaks of the two dyes are observed at the 
extremities and a roughly equal population of beads is observed at the centre. Alexa 647 and 
FITC are the two dyes detected by the system, representing the two bead populations 
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2 mg/mL collagen 
 
Figure 5.15. FACS density plots (left column) and the corresponding hiostograms (left column) 
for 3 regions within the mold for gradients generated for Fluorescent beads at 1.5 mg/mL 
collagen density. Region 1 and region 5 represent the extremities of the mold while region 3 
represents the centre. As expected, prevalent peaks of the two dyes are observed at the 
extremities and a roughly equal population of beads is observed at the centre. Alexa 647 and 
FITC are the two dyes detected by the system, representing the two bead populations 
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Figure 5.16. The new design for the microfluidic chip. Instead of having a separate device and 
mold assembly, we have integrated both into a single chip, reducing the number of interfaces in 
the system 
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Figure 5.17. Osteoblast viability 0 hrs and 6 hrs after generating the gradient mold. A high 
viability is observed indicating that the gradient formation process does not severely impact 
cells.  
 
 
 
 
 
 
Figure 5.18.  A confocal microscopy image of the HSCs within the mold. The markers c-kit and 
Sca-1 can be detected on the cell surface as seen in the figure on the right. Their corresponding 
spectra can be identified, as shown on the left.  
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CHAPTER 6: CONCLUSIONS 
 
Recognizing the need for an effective biomaterial tool for understanding the kinetics and 
mechanisms of cell-cell interactions involved in the HSC niche, our efforts were directed 
towards creating a biomaterial tool capable of providing a controllable local microenvironment. 
The solution we provide for understanding these HSC – niche cell interactions is using creating 
hydrogels with gradient properties such that the local environment gradually changes within the 
material. This is a high throughput process that enables the study of multiple parameters and 
their possible combinations that influence HSC fate.  
Using microfluidic device technology, we have been successful in creating the desired 3D 
cell-based hydrogel gradients. Our current work focuses on the use of collagen type I as the 
ECM. The micro fluidic device used for creating the gradients was first testing via fluorescent 
microbeads. These experiments, while successfully proving the utility of our system, provided a 
platform for generating gradients using cells. The quality of the gradients was assessed through 
the use of fluorescence image scanning and flow cytometry. These methods provided a way to 
quantify the bead population within the gradient. Cell gradients were also successfully created 
using this method. Based on the results from the opposing gradient graphs, it is apparent that 
further improvements are required in the design of our biomaterial system. The frontline changes 
involved include making the system more compact by combining the device and the mold and 
modifying the micro channels so as to improve fluid flow within them. Preliminary viability 
studies on the cells embedded in the ECM show encouraging results and warrant further work.  
We have demonstrated the versatility of our biomaterial system by creating gradients that  
1) Vary in ECM composition (different collagen densities) 
2) Vary in cell composition and size (beads, osteoblasts and HSCs had varied diameters) 
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While creating cell gradients is an important aspect for understanding cell-cell interactions, we 
also aim to create hydrogels that have gradients in the ECM composition and soluble regulators.  
The ability to generate gradients with a varied ECM density while also harboring a gradient 
in cell density offers us flexibility in testing a greater number of possible local environments. 
This allows us to exercise a greater control over the microenvironment, an important attribute for 
emulating the HSC niche. Another interesting possibility offered by this system is its ability to 
generate a gradient of soluble regulator, (eg. CXCL12), concentrations throughout the hydrogel. 
This provides us with the means to assess the influence of soluble regulators on cell-cell 
interactions with a high number of variable parameters. Finally, it needs to be recognized that 
our system need not be limited to only two inputs (or cell types). The HSC niche is a complex 
system involving a lot of cell types. By modifying the micro channel pattern, it is possible to 
include more than two inputs for our system.  
We have created a novel class of collagen-based biomaterials that mimic patterned 
heterogeneities found in the native BM. The key aspect of our system is its ability to generate 3-
dimensional cell gradients. This project will develop transformative new tools to systematically 
explore the significance of cell-based cues on HSC fate. Improved understanding of HSC fate 
decision is critical for optimizing biomaterial systems for ex vivo expansion of clinically relevant 
hematopoietic cells and for studying the etiology, niche regulation and treatment of 
hematopoietic pathologies.  
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APPENDIX A: PROTOCOLS 
 
A.1 Synthesis of silicon master wafer and PDMS microfluidic device 
 
SUPPLIES 
1) Si wafer 
2) SU8-2050 negative photoresist 
3) Isopropanol 
4) Acetone 
5) Polyethylene glycol monoethyl acetate (PGMEA) 
6) Silane 
 
EQUIPMENT 
1) Spin Coater 
2) UV Source 
3) 2 hot plates 
 
PROCEDURE 
1. Turn on the yellow clean room light 
 
2. Sign into the log book 
 
3. Put on booties, frock, and cap 
 
4. Turn on UV exposure tool 
 
5. Log into UV sign-in book 
a. Must wait 30 minutes after use to turn back on 
 
6. Flip power switch to turn on 
a. This is the switch on the back. 
b. Wait about 15 minutes to turn on the UV light itself by flipping ―start‖ 
 
7. Pre-heat the hot plates: 
a. 65°C 
b. 95°C 
c. It is better to change the aluminum foil on the hot plates to ensure that it is smooth 
d. To turn on the plates, press ENTER—plate temp—the temp you want—ENTER 
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8. Spin coat: 
a. Turn on the Nitrogen (brown nob) 
b. Enter the recipe you want 
i. Our recipe is #25 
ii. First layer, follow chart for 100 microns 
iii. Second layer, follow chart for 50 microns 
c. Check to make sure that the spin coat is clean. 
i. If not, clean the spin coat device with acetone and replace the foil 
 
Wafers: 
1. Helpful notes: 
a. Only place stuff on the shiny side of the wafer 
b. Before using, wash with acetone, then isopropanol, then dry with N-gun. 
c. Place the wafer as close to the center of the spin coat device as possible with the 
shiny side up. 
 
2. Place (estimate) 3 mL of SU-8 2050 on the spin coat 
a. Be sure to catch the tendril of SU-8 2050 
b. Wipe the bottle off after use 
 
3. Throw away the use towel in the flammable cabinet garbage 
 
Spin coat procedure and soft bake Part I: 
1. Turn on the vacuum pump making sure that the nozzle is pointed outward 
 
2. Check your spin coat protocol one more time to be safe 
 
3. ―Start‖ the spin coat cycle 
 
4. When done, transfer to 65°C for 5 minutes 
 
5. Move to 95°C and leave for 15 minutes 
a. While baking, place a glass cover over to prevent dust from settling on the gel 
 
6. Cool the silicon plates on the metal edge of the fume hood 
 
7. The soft bake is now finished 
 
UV exposure #1: 
1. Place the mask over the wafer with the ink side down and place under the UV light 
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2. Place the square glass cover over the mask so that it lays flat against the gel 
 
3. Expose for 23 seconds (or about 20 seconds) 
 
4. Press ―expose‖ after putting in the respective time of exposure. 
a. Be sure to wear the UV glasses while exposing 
 
Spin coat procedure and soft bake Part II: 
1. First, check your program so that it matches the 50 micron parameters 
 
2. Pour on 2 mL of SU-8 2050 onto the disk and press ―start‖ 
 
3. When done, transfer to 65°C for 1 minute 
 
4. Move to 95°C and leave for 6 minutes 
a. While baking, place a glass cover over to prevent dust from settling on the gel 
b. This soft bake will serve as the post-exposure bake for your first layer 
 
UV exposure #2: 
1. Now, you must align the basic flow design with the herringbone mask 
 
2. Once you are satisfied with the alignment… 
 
3. Expose to UV at 80 mJ/cm² 
 
Post-exposure bake: 
1. 65°C for 1 minute 
95°C for 6 minutes 
a. While baking, place a glass cover over to prevent dust from settling on the gel 
 
Spin coat clean up: 
1. While baking… 
 
2. Rinse the chuck with acetone and wipe 
 
3. Replace foil 
 
4. Wipe down the dish ware that was used 
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Development: 
1. Develop with Propylene glycol monomethyl ether acetate (PGMEA) 
 
2. Pour in about 1 cm (in height) to the beaker 
 
3. Set disc into solution 
 
4. Wait 10-15 minutes or until all SU-8 is dissolved 
 
5. Rinse with isopropanol 
 
6. Blow dry with the N-gun 
 
7. Rinse with PGMEA then isopropanol 
 
Clean up: 
1. Pour out liquids into the waste container 
 
2. SU-8 is negative photo-resistant 
a. Rinse with acetone 
 
3. Wipe out all glassware 
 
Silanization process 
 
1) Place the clean wafer in a Petri dish and place it in a degasser unit 
 
2) Add 2 µL of silane into a container placed inside the unit. Leave the tip inside as well 
 
3) Seal the unit and pull house vacuum. Make sure that the degasser unit is completely 
sealed off  
 
4) Leave the degasser unit under vacuum over night or about 12 hours 
 
5) After the stipulated time, release the vacuum 
 
6) Keep the wafer inside the Petri dish and cover it with the lid for future use 
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A.2 Creating a PDMS device from the master wafer 
 
SUPPLIES 
1) 30 g PDMS 
2) 3 g monomer 
3) Glass slides 
4) 22 gauge needle 
5) Isopropanol 
6) Distilled water 
7) 10% Alconox solution 
 
EQUIPMENT 
1) Plasma cleaner 
2) 70° oven  
3) Degasser unit 
4) Vacuum pump 
5) Needle punch 
 
PROCEDURE 
1) Mix 30g of PDMS with 3g monomer in a plastic up. Mix until the solution becomes 
white and viscous with a lot of tiny air bubbles 
 
2) Place the cup in the degasser unit and connect it to a vacuum pump.  
 
3) Start the pump. The vacuum forces the air bubbles mixed within the PDMS solution to 
escape from the solution.  
 
4) Keep unit under vacuum until no more bubbles can be seen 
 
5) Release the vacuum and pour the PDMS solution into the Petri dish containing the Si 
master wafer 
 
6) Ensure no bubbles exist in the poured solution. Place the dish in the oven for 1 hour to 
cure the PDMS 
 
7) After 1 hour, remove the wafer from the oven. The PDMS has now gelled is quite firm 
 
8) With a scalpel, cut the patterned part of the PDMS off the wafer. Ensure not to damage 
the wafer while doing so 
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9) Tape the patterned side of PDMS with scotch tape. This prevents dust from settling on it 
 
10) Polish off the tip of the 22 gauge needle such that it becomes evenly round.  
 
11) Using a needle punch, carefully punch holes, through the patterned side, into all the inlets 
and outlets of the devices. These are marked with tiny holes on the device 
 
12) Clean a glass slide first with the 10% alconox solution followed by distilled water and 
isopropanol. Blow dry with a Nitrogen gun 
 
13) Remove the tap from the device and place it, patterned side up, into the plasma cleaner 
along with the glass slide 
 
14) Start the vacuum pump and wait until the pressure inside goes below 500 mtorr.  
 
15) Once the desired pressure is reached, turn the plasma cleaner on high for 1 min 10 secs. 
Release the vacuum valve once midway so as to let a minuscule amount of oxygen in 
 
16) Turn off the plasma cleaner after the stipulated time, turn off the vacuum pump and 
release the vacuum inside 
 
17) Remove the glass slide and PDMS device. Place the patterned side of the device on top of 
the glass slide. Press to ensure firm bonding. Do this as quickly as possible.  
 
18) Leave the device in the oven for 1 hour to ensure complete bonding between the glass 
and PDMS 
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A.3 MC3T3-E1 cell passaging protocol 
 
SUPPLIES 
1) Complete MEM-α medium 
2) Sterile Phosphate Buffered Saline (PBS, Cat No. 20012-043, Invitrogen Inc., Carlsbad, 
CA) 
3) Trypsin-EDTA 
4) Trypan Blue 
 
EQUIPMENT 
1) Hausser Phase contrast hemacytometer 
2) Inverted phase contrast microscope 
3) Tabletop centrifuge 
 
PROCEDURE 
 
1) Warm complete MEM-α medium, sterile PBS (Invitrogen), and 4 ml Trypsin (Invitrogen) 
per T75 flask to be passaged in a water bath at 37 C.  
 
2) When the medium, PBS and Trypsin are warm, wipe them dry with paper towel and spray 
with 70% ethanol before placing in the sterile hood.  
3) Remove all old medium from each flask, taking care not to scrape the cells with pipette 
tip. 
 
4) Add 10 ml of PBS per flask and leave the PBS in the flask to rinse the cells for 30 
seconds. Swirl gently to remove any excess medium from the cells. (For a T25 flask, use 5 
ml PBS) 
 
5) Remove the PBS and add 3 ml of Trypsin per flask (for a T25 flask, use 1.5 ml Trypsin). 
Return the flasks to the incubator for 4 minutes to allow for the cells to detach from the 
tissue culture plastic. If the cell suspension is not cloudy after 5 mins, shake the flask in 
order to detach the cells. Keep shaking until the trypsin solution turns cloudy.  
 
6) Add 6 ml of complete medium to each flask to neutralize the Trypsin and to flush cells off 
of the tissue culture plastic. (for a T25 flask, use 4 ml PBS) 
 
7) Remove the Trypsin, additional medium, and cells from the flask and put into a conical 
tube. Centrifuge the cells at 130 rcf for 7 minutes.  
 
8) Aspirate off the medium supernatant and add a total of 3 – 5 ml of medium to the conical 
tubes. This amount varies depending on how many conical tubes are used (i.e. how many 
flasks are passaged).  
 
9) Remove the 10 μl aliquot from the cell suspension.  
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10) Mix the 10 μl cell suspension aliquot with 10 μl of Trypan Blue (Fisher Scientific). 
Pipette several times to mix the stain and cell suspension.  
 
11) Place a cover slip on the hemacytometer (Fisher) and pipette 10 μl of the stain/cell 
suspension into the hemacytometer. 
 
12) Cell counts are performed in as many of the nine separate regions of the hemacytometer 
as is feasible. Average number of cells per region is used to calculate the total cell 
population. For this calculation, the dilution factor is typically 2 (1:1 ratio of cell 
suspension to Trypan Blue). 
 
Total Cell Population = (Mean Cells per Region) * Dilution * 10,000 * (Cell Suspension 
Volume) 
 
13) Add 14 ml of complete MEM-α medium to each new T75 flask to be seeded (or 4 ml for 
a T25 flask). Add the appropriate volume of the concentrated cell solution to place 
approx 0.8 million cells in the T75 (to be passaged after a week). For the near-future use, 
seed 1 million cells in a T25 flask. They will be ready (confluent) the day after.  
 
14) Place the flask(s) into the incubator. Check the confluence every 24 hours and feed cells 
every 48 hours.  
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A.4 Protocol for tagging cells with fluorescent dyes 
 
SUPPLIES 
1) CMFDA and CMTPX dyes (Invitrogen) 
2) MC3T3-E1 cells 
3) Complete α-MEM media 
4) DMSO 
 
PROCEDURE 
1) Culture cells in a T-25 flask 
 
2) Mix the as-available dye tube with 10 µL of DMSO 
 
3) Pipette 5mL of media into a conical tube 
 
4) Add 5 µL of dye solution to the media. Mix well 
 
5) Pipette out old media from the T-25 flask. Pipette the new media into the flask  
 
6) Incubate for 20 minutes 
 
7) Following incubation, pipette out the media. Rinse twice with PBS 
 
8) Follow protocol for cell passaging (A.3) 
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A.5 Bone marrow harvest protocol for HSPC harvest from mice 
 
Animals to sac: 
WT: Jax C57B6 mouse strain 
 
FACS Antibodies:  
Lineage cocktail [CD5, CD45R (B220), CD11b, Anti-Gr-1 (Ly-6G/C), 7-4, Ter-119] 
Sca-1 
c-Kit 
 
SUPPLIES: 
1) 70% ethanol solution 
2) Surgical tools – scissors, tweezers 
3) Timer 
4) Pen 
5) Petri dish 
6) Vacuum chamber – vacuum flask, plastic tubing, and glass pipettes for aspiration 
7) Syringe 
8) Pre-cooled reagents– ACK lysis buffer, separation buffer, PBS/2%FBS (at 4°C) 
PBS/2%FBS: 1 tube with ~25ml to store bones, ~40mL for filtering out bone pieces, 35mL 
for quenching after, ~5mL for miscellaneous use  
 Have ~120mL ready  
 Separation buffer: Have ~20mL ready 
9) 40 µmcell strainer 
 
PROCEDURE 
Isolation of BM cells from mouse: 
1) Sacrifice mouse via CO2inhalation. (Make sure to bring 70% ethanol solution, surgical 
scissors and tweezers, gloves, and a pen to the animal facilities lab.) 
 
2) Remove tibia and femur (entire length incl. head of femur)from both sides. Remove any 
attached muscle (via gentle Kim-wipe rubbing). Place into PBS+2%FBS solution. 
 
3) Place bones into (cleaned/autoclaved) mortar with some PBS+2%FBS.Gently crush the 
bones using a pestle. Do not grind with continuous motion: use a gentle up-and-down 
motion. 
 
4) Place PBS+2%FBS + ground bones through a 40m cell strainer into 50ml conical tube; 
rinse mortar and pestle with ~25–40 mL of PBS+2%FBS buffer through strainer as well. 
 
5) Centrifuge cells: 1400 rpm, 5 minutes, 4oC. Aspirate supernatant. 
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6) Resuspend cells in 5ml ACK lysis buffer, vortex well. Let stand 5 min (no more!) on ice. 
Quench with 35ml PBS+2%FBS 
 
7) Centrifuge cells: 1400 rpm, 5 minutes, 4oC. Aspirate supernatant. 
 
Pre-enrichment of BM cells via negative selection for Lin markers using Miltenyi pre-
enrichment MS columnmagnetic separation: (Note: Work fast, keep cells on ice, and use 
pre-cooled (4 – 8C) reagents) 
1) Resuspend cells in 4ml PBS + 2% FBS 
 
2) Count live cells from 10L aliquot (+10L Trypan blue).  Dilute by a factor of 5 (instead 
of usual 2) for easy counting as there will be a lot of cells. 
 WT 
Avg. count (hemacytometer grid)  
Total # cells/4mL  
 
FACS analysis/sorting for further enrichment in LSK population: All steps done on ice 
1) Resuspend cells in 400 – 500 L PBS/FBS. Add more until all the cell clusters are 
dissolved. Usually comes to 1 mL.  
 
2) Add 5 L of 0.5 mg/mLFc receptor blocking antibody to achieve of 0.5 g/mL (Note: the 
actual concentration upon adding 5 L is much higher but is done as precaution). Sit 10‘ 
on ice.  
 
3) Spin down: 1400 rpm; 5 minutes; 4C. Aspirate the supernatant. Resuspend in 1mL or a 
smaller desired volume.  
 
4) Make control and sorting samples: 1E6 cells per control and the rest for sorting.  
 
5) Add antibody cocktails (Lin, Sca-1, and c-Kit); Sit 20‘ on ice. 
 
Lin cocktail Dilution For 100 L cocktail 
CD5 1:200 0.5 
B220 1:300 0.33 
Mac-1 1:320 0.31 
CD8a 1:200 0.5 
Gr-1 1:350 0.29 
Ter-119 1:320 0.31 
PBS + 2% FBS  97.76 
  Note.  Dilutions when antibodies are at 0.5 mg/mL. 
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# Control # cells (million) Amount of 
control (μL) 
1 Unstained 1 0 
2 PI 1 2 
3 APC 1 0.5 
4 PE 1 0.5 
5 FITC 1 0.5 
 
 
Antibody cocktail Amount 
Lin cocktail 10 λ 
Sca-1-PE 10 λ 
c-kit-APC 10 λ 
TOTAL 30 λ 
 
6) Add 100λ of PI stock solution into 10mL PBS+2%FBS to make PI working solution. 
Add 25µL of the PI working solution (1:2 dilution) to PI control and WBM,  
 
# FACS Tube Contents 
1 Unstained control WBM 
2 PI control WBM, PI 
3 APC control WBM, Sca-1-PE 
4 PE control WBM, c-kit-APC 
5 FITC control WBM, Lin-FITC 
6 WBM WBM, PI, c-kit-PE, Sca-1-APC, Lin-FITC 
 
7) Wash in 3 mL PBS/2% FBS. 
 
8) Centrifuge cells: 1400 rpm, 5 minutes, 4oC. 
 
9) For controls, resuspend in 500 L PBS+2% FBS; pipette up/down, vortex to generate 
single cell suspension.  
 
10) For sorting sample, resuspend in PBS+2% FBS to achieve concentration of 10E6 
cells/mL; pipette up/down, vortex to generate single cell suspension.  
 
11) Filter into new tubes. 
 
12) Flow analysis/sorting on each population.  
 
For Sorting: 10E6 cells/mL 
 
13) Filter the cells through a 40 μm cell strainer for easier sorting 
 
14) Place the sorting tube in an ice bath for better results. 
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A.6 Gradient generation protocol 
 
SUPPLIES 
1) Microfluidic device 
2) Fluorescent cells or beads 
3) Petri dish 
4) High vacuum grease 
5) Distilled water or sterile PBS 
6) Vacuum chamber 
7) Collagen solution 
 
EQUIPMENT 
1) Vacuum pump 
2) Harvard Syringe Pump 
3) Timer 
 
PROCEDURE 
1) Prepare a collagen solution of the desired density of either the beads or cells and keep it 
on ice 
 
2) Pour distilled water (for beads) or sterile PBS (for cells) in a deep welled Petri dish 
 
3) Attach one glass slide to the base of the mold using super glue. Grease the top part of the 
mold with high vacuum grease 
 
4) Using a metal wire, poke each of the 20 holes in the mold to ensure the tubes aren‘t 
blocked 
 
5) Attach a 27 gauge needle to a 1 mL syringe. Attach a plastic tubing of the appropriate 
size to the needle 
 
6) Connect the metal tubes to the PDMS device. Connect two syringes, filled with water, to 
the inlets of the PDMS device by inserting the other end of the plastic tubes into the 
PDMS device 
 
7) Gently push the syringe plunger to check fluid flow through the channels and the tubes. 
Water should exit from each of the 10 inlets connected to the device and enter the cavity 
 
8) Place this assembly in the Petri dish filled with water (or PBS) such that the mold cavity 
is completely immersed in water 
 
9) Place the entire assembly in the vacuum chamber and pull vacuum on the system. 
Bubbles will observed through the water surface and any interfaces 
 
10) Leave the vacuum pump on for 5 minutes, tapping the chamber intermittently, so as to 
release the bubbles on the surface 
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11) Turn off the pump and release the vacuum 
 
12) Remove the dish from the chamber. Take care to ensure that the mold does not break the 
water surface beyond this point.  
 
13) Using two fresh syringes and 17 gauge needles pump the collagen solutions in the 
respective syringes.  
 
14) Remove the water-filled syringes attached to the device and plug the syringes containing 
the collagen solutions to it 
 
15) Load the syringes onto the syringe pump. Set the flow rate appropriately, based on the 
collagen density.  
 
16) Slide a glass slide on top of the mold so as to completely seal the mold 
 
17) Turn on the syringe pump and let the solutions flow for the desired amount of time.  
 
18) After the stipulated time, turn off the pump and detach the mold from the device.  
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A.7 Preparing the collagen solutions 
 
SUPPLIES 
1) Collagen Type 1 (BD Biosciences) 
2) HEPES solution 
3) NAOH (0.4 M) 
4) Completer α-MEM media 
5) Beads/Cells 
 
PROCEDURE 
 
1) The BD Biosciences collagen bottle comes in a specific concentration. Therefore, 
concentrations lower than the original concentration can be made 
 
2) For a given total volume of solution, calculate the volume of collagen solution based on 
the bottle concentration (collagen is viscous so pipette slowly and wait for a while with 
the tip dipped in the solution) 
 
3) HEPES volume = 2.5% of the total volume 
 
4) Add the volume of cells based on the number of cells required 
 
5) Fill out the rest of the volume with media and the appropriate amount of NaOH (based on 
the calibration curve) 
 
Making the NaOH calibration curve 
 
1) Prepare to make a final solution volume of 2 mL.  
 
2) Pipette out 1.5 mL of media in a container (tiny beaker, centrifuge tube etc) 
 
3) For 1, 1.5, 2, 2.5, 3 mg/mL of collagen concentration, add the appropriate amount of 
collagen (if the total volume of media + collagen exceeds 2 mL, reduce the media volume) 
 
4) Add 50 uL of HEPES solution (2.5% of 2) 
 
5) Start by adding 10 uL of 0.4 M NaOH and measuring the pH with a pH probe. Make sure 
to mix the solution well before measuring pH. Keep adding more NaOH until a pH of 7.4 
+/- 0.1 is obtained. 
 
6) Plot the collagen concentration on the x-axis and the final NaOH volume on the y-axis to 
get the calibration curve 
 
7) Repeat process for a total solution volume of 1 mL. This is done to check the correlation 
between solution volume and NaOH volume needed for neutralization 
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Example calculation: 
 
Objective: Make a 2 mL solution with collagen concentration of 2.5 mg/mL 
Chemicals: 9.03 mg/mL collagen solution 
                    0.4 M NaOH 
                    HEPES solution 
                    Media 
 
Calculations: 
 
1) Calculate collagen volume:     
  
  
        
  
  
     
           
 
2) Therefore, I will add only 1.2 mL of media to begin with, followed by 0.553 mL collagen 
(always add media first as adding collagen to it is easier than the other way round) 
 
3) Add 50 uL of HEPES solution (2.5% of 2 mL) 
 
4) Start by adding 20 uL of NaOH and measuring pH and keep adding until desired pH is 
reached 
 
5) Bring total solution volume upto 2 mL by adding more media 
 
6) In the future, use the final NaOH value (and/or use calibration curve) to bypass step 4 and 
5.  
 
 
Collagen solution density 
(mg/mL) 
Total solution volume 
(mL) 
NaOH volume 
(µL) 
1 1 0 
1.5 1 10 
2 1 15 
2.5 1 20 
 
Table A.6.1  NaOH volume required for the given collagen densities for a solution volume of 1 
mL, based on the calibration curve data. 
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A.8 Fluorescence image scanning of generated gradients 
 
EQUIPMENT 
1) Typhoon 9400 Image Scanner (GE Electronics) 
2) ImageJ Software 
 
PROCEDURE 
1) Place the generated gradient mold (with both coverslips on) on the Typhoon scanner 
 
2) Scan for the appropriate excitation and emission spectra  
 
3) After the scan, open the image files using ImageJ software 
 
4) Split the image into five regions. Using the ―Measure‖ function, serially measure the 
average fluorescence intensity of the regions. Also measure the intensity of the standard 
solution  
 
5) Paste the data into Excel  
 
6) For obtaining the normalized intensity, divide the intensity of the regions by the standard 
solution intensity. This forms the basis for comparison 
 
7) Plot the average intensity as a function of position 
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A.9 Isolation of mold regions and characterization using FACS 
 
SUPPLIES 
1) Metal comb  
2) PBS 
3) Gradient mold  
 
EQUIPMENT 
1) BD FACS Flow Cytometer  
 
PROCEDURE 
1) After generating the gradient, gently slide off the top coverslip from the mold. Do this 
slowly to ensure that the gradient isn‘t disturbed 
 
2) Place the metal comb into the mold cavity such that the space is equally divided into 5 
parts 
 
3) Using a pipette, remove 20 µL of solution from within the cavity for each of the regions 
 
4) Mix this solution with 180 µL of PBS in a centrifuge tube. Pipette multiple times so as to 
completely dissolve the collagen 
 
5) Run the individual samples through the FACS machine 
 
6) Analyze using the FACS software 
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A.10 Live/Dead assay to assess viability of cells in the mold 
 
SUPPLIES 
1) Live/Dead cytotoxicity kit (Invitrogen) 
2) PBS 
3) Mat Tek dishes 
4) Metal comb 
 
EQUIPMENT 
1) Fluorescence microscope 
 
PROCEDURE 
1) After generating the desired mold, slide off the coverslip from the mold such that one 
surface of the mold is left open to air, facilitating the diffusion of oxygen to the cells 
 
2) After the appropriate culture period, isolate the five sections of the mold using the metal 
comb, as explained in Appendix A.8. 
 
3) To prepare the live/dead assay, pipette 500 µL of PBS in a centrifuge tube 
 
4) Add 1 µL of EthD solution to the PBS, followed by 0.6 µL of the calcein AM solution 
 
5) Vortex well 
 
6) Use 100 µL of this live/dead solution per mold sample 
 
7) Mix the solutions well and incubate at 37 °C for 15 minutes 
 
8) Pipette the solution onto a MatTek dish and observe under a fluorescence microscope 
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